1,6—Diphosphate Fructose in Heart Failure:A Systematic Review
- VernacularTitle:1,6—二磷酸果糖治疗心力衰竭有效性的系统评价
- Author:
Shumei WANG
;
Fang LIU
;
Suodi ZHAI
- Publication Type:Journal Article
- Keywords:
1,6—Fructosediphosphate;
Heart failuere;
Evidence-based medicine;
Systematic review
- From:
China Pharmacy
2005;0(23):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To assess the effectiveness of 1,6—diphosphate fructose(FDP)in the treatment of heart failure(HF).METHODS:Biomedical databases,including Medline,Embase,Cochrane Controlled Trials Register,CBM and CNKI were searched.Clinical trials were screened according to the inclusion criteria formulated beforehand,quality assessments and meta anylysis of included studies were carried out.RESULTS:14 randomized controlled trial were included,and all of them were carried out in China.Jadad score of the studies were all 1.None of the 14 trials carried out by follow-up domization for long-term effect evulation Meta-analysis of 14 trials showed that FDP can increase effective rate in the treatment of HF,and OR(95%CI)was 3.79(2.58,5.57).5 studies showed that FDP can increase cardic index,and WMD(95%CI)was 0.40(0.34,0.46).6 studies showed that FDP can increase ejection fraction(EF)with WMD(95%CI)8.31(5.51,11.11).4 studies showed that FDP can decrease left ventricular end systolic and diastolic diameter,and WMD was—3.25(—4.74,—1.76)and—3.75(—6.94,—0.56).No long-term effects were reported by the included studies.CONCLUSIONS:According to present evidence,FDP can increase the treatment effective rate when added to the basic treatment of HF.FDP can improve heart function and lefe ventricular construction showed by the indicators.However,the poor quality of the studies decreased the persuasion of the results.Large-scale and well-designed RCTs with enough follow-ups should be carried out to provide further evidence for the use of FDP.
